PPD infectious
tuberculin skin test PPD interpretation
tuberculin skin test PPD Mantoux induration reading

This clinical photograph displays a Mantoux tuberculin skin test site on the volar aspect of a human forearm, 72 hours post-intradermal injection of purified protein derivative (PPD). The visual findings demonstrate a positive reaction characterized by a central, well-defined zone of induration exhibiting a reddish-purple, dusky hue. Surrounding the induration is a peripheral ring of lighter pink erythema. The lesion is roughly circular in morphology, measuring approximately 24 mm in diameter. The surrounding skin appears otherwise normal with standard follicular distribution. This image is a classic educational representation used in infectious disease and pulmonology to illustrate delayed-type hypersensitivity (Type IV) reactions and screening for Mycobacterium tuberculosis infection. Key diagnostic features highlighted include the palpable firmness (induration) and the significant size threshold indicating a positive result in clinical diagnostic protocols.

This clinical photograph displays a positive Mantoux tuberculin skin test on the volar aspect of a patient's forearm. The visual hallmark is a central, well-demarcated area of induration, appearing as a raised, firm, and palpable plaque. The indurated center exhibits a slightly lighter, yellowish-tan coloration with a textured, peau d'orange appearance compared to the surrounding skin. Encircling this central induration is a broad, poorly defined halo of erythema (redness). The reaction site is roughly circular, and a small central puncture mark from the intradermal injection is visible. In the clinical context provided, this measure of 28 mm represents a strongly positive reaction, indicating a delayed-type hypersensitivity response to Purified Protein Derivative (PPD). Such a robust reaction is highly suggestive of infection with Mycobacterium tuberculosis and, in this specific case, correlates with systemic findings of ocular and pulmonary tuberculosis.

This clinical photograph displays a positive Tuberculin Skin Test (Mantoux test) on the forearm of a patient. The image shows a well-defined, raised erythematous plaque characterizing a strongly reactive 19 mm PPD (purified protein derivative) result. The lesion is primarily a reddish-pink circular area of induration, exhibiting a slightly bumpy, textured surface with fine papular elevations. The surrounding skin shows mild peripheral erythema that fades into the normal skin tone. This visual represents a delayed-type hypersensitivity reaction (Type IV), indicative of current or past infection with Mycobacterium tuberculosis. The educational focus is on the clinical assessment of induration rather than just erythema to determine a positive diagnostic result in tuberculosis screening.

| Induration | Group |
|---|---|
| ≥ 5 mm | HIV-positive individuals; recent close contacts of active TB; fibrotic changes on CXR consistent with old TB; organ transplant recipients; immunosuppressed patients (e.g., on ≥15 mg/day prednisone) |
| ≥ 10 mm | Recent immigrants from high-prevalence countries (<5 years); IV drug users; residents/employees of high-risk congregate settings (prisons, nursing homes, hospitals); mycobacteriology lab personnel; children <4 years; those with medical risk factors (diabetes, silicosis, CKD, malignancy, low body weight) |
| ≥ 15 mm | Any person with no known risk factors (general population screening) |
| Feature | PPD (TST) | IGRA (QuantiFERON, T-SPOT) |
|---|---|---|
| Method | Intradermal injection, read at 48-72h | In vitro blood test |
| BCG interference | Yes - can cause false positive | Minimal/no |
| NTM interference | Yes | Less |
| Requires 2 visits | Yes | No |
| Anergy affected | Yes | Yes |
| Differentiates latent vs. active | No | No |
| Cost | Lower | Higher |
Tell me about these tests for my infectious ward
Gram stain bacteria purple red microscopy

This light microscopy image demonstrates a Gram stain of an excised clinical sample, typically used in microbiology for diagnostic identification. The central focus shows a dense cluster of Gram-variable filamentous rods, characteristic of Actinomyces species. These organisms appear as dark, elongated, branching, thread-like structures. Some filaments exhibit a beaded appearance, staining more intensely (Gram-positive/purple) or less intensely (Gram-negative/pink) along their length. The background consists of host cellular debris and inflammatory cells, which are counterstained pink/red with safranin. These background elements include various eukaryotic cells and likely polymorphonuclear leukocytes. This visual is highly representative of Actinomycosis, demonstrating the classic 'sulfur granule' or 'tangled mass' morphology often seen in abscess aspirates or tissue samples. It serves as a critical educational tool for distinguishing filamentous bacteria from standard cocci or bacilli and highlights the importance of Gram stain variability in clinical diagnostics.

This composite diagnostic image presents two light microscopy views of pleural fluid highlighting the microbiological identification of Nocardia species. Panel (a) shows a Gram stain at high magnification, demonstrating Gram-positive (purple-stained), thin, beaded, and branching filamentous bacteria. Panel (b) illustrates a modified Ziehl-Neelsen (ZN) stain of the same clinical specimen. The bacteria exhibit weak acid-fast properties, characterized by pink-to-red filamentous structures that retain the primary stain against a light blue counterstained background. Arrows in both panels indicate the characteristic filamentous and branching morphology. This combination of Gram-positive branching filaments and partial acid-fastness is a key diagnostic feature used to distinguish Nocardia from other filamentous bacteria like Actinomyces. These findings are clinically significant in diagnosing thoracic nocardiosis in immunocompromised patients or those with pre-existing pulmonary disease.
| Finding | Significance |
|---|---|
| Ring forms in RBCs | Malaria (P. falciparum, P. vivax, etc.) |
| Toxic granulation, band forms | Bacterial sepsis |
| Atypical lymphocytes | EBV (mononucleosis), CMV |
| Schistocytes | Thrombotic microangiopathy (HUS/TTP) |
| Intraerythrocytic rings/Maltese cross | Babesiosis |
| Result | Color | Examples |
|---|---|---|
| Gram-positive cocci in clusters | Purple | S. aureus |
| Gram-positive cocci in chains | Purple | Streptococcus spp. |
| Gram-negative diplococci | Pink | N. meningitidis, N. gonorrhoeae |
| Gram-negative rods | Pink | E. coli, Klebsiella, Pseudomonas |
| Gram-positive rods | Purple | Listeria, Clostridium |

| Type | Route | PPE Required | Examples |
|---|---|---|---|
| Contact | Touch/fomites | Gloves + gown | MRSA, VRE, C. diff, scabies, impetigo |
| Droplet | Large droplets (>5 µm) | Surgical mask + gloves | Influenza, meningococcal meningitis, mumps, pertussis |
| Airborne | Small droplets (<5 µm) | N95 respirator + negative-pressure room | TB, measles, varicella, SARS-CoV-2 (aerosol-generating procedures) |
| Protective / Reverse | Protect immunocompromised patient | Positive-pressure room, HEPA filtration | Neutropenic patients, BMT recipients |
| Wound Type | Preferred Method |
|---|---|
| Abscess / pustule | Aspirate pus with needle/syringe before opening; send for C&S + Gram stain |
| Open wound / ulcer | Cleanse wound first with saline; use Levine technique - swab the wound base with firm rotation over 1 cm² area for 5 seconds |
| Tissue biopsy | Best for deep infections, leishmaniasis, necrotizing fasciitis - punch biopsy or surgical sample |
| Blister / vesicle | Unroof and swab base (Tzanck smear + viral culture for HSV/VZV) |
| Sinus tract | Probe and culture the deepest accessible area, not the opening |
| Finding | Bacterial | Viral | TB/Fungal |
|---|---|---|---|
| Appearance | Turbid/cloudy | Clear | Clear/slightly turbid |
| WBC | >1000/µL, neutrophils | 10-1000/µL, lymphocytes | 100-500/µL, lymphocytes |
| Protein | Very high (>100 mg/dL) | Normal/mildly raised | High (100-500 mg/dL) |
| Glucose | Very low (<45 mg/dL) | Normal | Low |
| Gram stain | Often positive | Negative | Negative (AFB in TB) |
| Panel | Key Interpretation Points |
|---|---|
| CBC | WBC with differential - neutrophilia (bacterial), lymphocytosis (viral), eosinophilia (parasites/fungi), neutropenia (risk for opportunistic infections) |
| CRP / ESR / Procalcitonin | PCT >0.5 ng/mL favors bacterial infection; PCT-guided therapy can reduce antibiotic duration |
| Blood cultures | Identify organism + susceptibilities; 2 positive sets = true bacteremia; single set CoNS = likely contaminant |
| LFTs / Renal function | Drug dosing adjustments; aminoglycosides, vancomycin, acyclovir, fluconazole all require renal dose adjustment |
| Gram stain & culture | Correlate morphology (Gram stain) with colony type and sensitivities |
| Serologies | Acute vs. convalescent titers; IgM = acute infection; IgG = past exposure/immunity |
| CSF analysis | See LP table above |
| HIV serology / viral loads | 4th generation Ag/Ab test detects both p24 antigen and antibody; viral load guides treatment and infectivity |
Make sure I have every detail that I need
lumbar puncture spinal needle CSF collection technique positioning

This clinical procedural photograph illustrates a subarachnoid puncture, commonly referred to as a lumbar puncture, being performed for cerebrospinal fluid (CSF) collection or drainage. The image shows a spinal needle inserted into the lumbar region of a patient, specifically at the L2-L3 interspace. The procedural site is prepared with sterile blue surgical drapes. A key clinical finding is the visualization of clear, colorless fluid (CSF) dripping from the hub of the spinal needle into a sterile collection container, confirming successful entry into the subarachnoid space. This visual evidence of 'free-flow' is critical for diagnostic sampling and therapeutic pressure management. The photograph demonstrates proper aseptic technique and the lateral approach for accessing the lumbar cistern. It serves as an educational tool for medical students and clinicians to recognize the appearance of CSF during neurosurgical or neurological procedures, highlighting the correct anatomical positioning and procedural outcomes in a clinical setting.

A clinical photograph depicting a healthcare professional performing a lumbar puncture (spinal tap) on a patient in a clinical setting. The patient is positioned in a lateral decubitus posture, lying on their side with the spine flexed and knees drawn toward the chest to increase the interspinous space. The healthcare worker, wearing a white lab coat and sterile gloves, is shown inserting a spinal needle into the lumbar region, specifically targeting the subarachnoid space to collect cerebrospinal fluid (CSF). The visual captures the precise manual technique required for this invasive procedure. Contextually, this diagnostic maneuver is illustrated here as a critical step in staging African Sleeping Sickness (Human African Trypanosomiasis) to detect central nervous system involvement. This image serves as a teaching tool for neuro-diagnostic procedures and clinical manifestations of tropical diseases in resource-limited environments.
blood culture bottles aerobic anaerobic collection venipuncture

This clinical photograph captures a venipuncture procedure for blood collection, specifically from the brachial vein in the antecubital fossa of a patient's arm. The setup features a winged infusion set (butterfly needle) with a green safety shield, which is inserted into the vein. A flexible plastic extension tube connects the needle to a vacuum collection tube. The collection tube has a red cap, indicating it is likely a plain serum tube without anticoagulants, and is seen partially filled with dark venous blood. The patient's arm is positioned on a green medical cushion, with a practitioner's hand visible providing stabilization. This procedural image demonstrates the initial step in obtaining blood for Platelet-Rich Fibrin (PRF) preparation, highlighting the medical specialty of oral and maxillofacial surgery or regenerative medicine. The educational focus is on the aseptic technique and the specific equipment required for autologous blood harvesting.

This clinical photograph illustrates a venipuncture procedure for blood collection from the antecubital fossa of a patient's arm. A blue reusable tourniquet is applied to the mid-humerus region to facilitate venous distension. A healthcare professional, wearing white sterile gloves, is performing the procedure using a winged infusion set (butterfly needle), indicated by the green plastic 'wings' held at the puncture site. The needle is connected via flexible tubing to a vacuum-sealed blood collection tube (vacutainer) with a red-stoppered cap. The setup demonstrates standard aseptic technique and equipment used for obtaining venous blood samples, which in this clinical context is being utilized for the subsequent preparation of Leukocyte-Platelet-Rich Fibrin (L-PRF) for surgical use.
| Induration | Population |
|---|---|
| ≥ 5 mm | HIV-positive; recent close contact of active TB; fibrotic CXR changes consistent with old TB; organ transplant; patients on ≥15 mg/day prednisone; TNF inhibitor therapy |
| ≥ 10 mm | Recent immigrants (<5 yrs) from high-prevalence countries; IVDU; residents/employees of congregate settings; mycobacteriology lab staff; children <4 years; medical risk factors (DM, silicosis, CKD, haematologic malignancies, weight loss >10%) |
| ≥ 15 mm | All other persons with no risk factors |
| PPD | IGRA (QuantiFERON, T-SPOT) | |
|---|---|---|
| BCG cross-reaction | Yes | No |
| NTM cross-reaction | Yes | Minimal |
| Requires return visit | Yes (48-72h) | No (1 visit, blood test) |
| Reader variability | Yes | No |
| Preferred when | Low-cost setting, <5 yrs old | BCG-vaccinated, unreliable follow-up |
| Finding | Significance |
|---|---|
| Ring forms within RBCs (multiple rings per cell, banana-shaped gametocytes) | P. falciparum - malaria, SEVERE |
| Enlarged RBCs with ring + Schüffner's dots | P. vivax or P. ovale |
| RBCs normal size, ring + "Maltese cross" (tetrad form) | Babesiosis |
| Trypomastigotes (C-shaped organisms in plasma) | African trypanosomiasis |
| Spiral organisms between RBCs | Relapsing fever (Borrelia) |
| Toxic granulation (dark granules in neutrophils) | Bacterial sepsis |
| Döhle bodies (blue cytoplasmic inclusions in neutrophils) | Severe bacterial infection, sepsis |
| Left shift (bands > 10%, metamyelocytes, myelocytes) | Bacterial infection, sepsis |
| Atypical lymphocytes (large, lobulated, monospot) | EBV mononucleosis, CMV, acute HIV |
| Neutropenia | Typhoid, viral infections, bone marrow suppression |
| Reactive thrombocytosis | Post-infection, asplenic patients |
| Thrombocytopenia | Malaria, dengue, HUS, sepsis, DIC |
| Schistocytes + thrombocytopenia | HUS, TTP (associated with STEC infection, HIV) |
| Colour | Interpretation |
|---|---|
| Purple/violet | Gram-positive (thick peptidoglycan retains crystal violet-iodine complex) |
| Pink/red | Gram-negative (thin peptidoglycan, outer membrane loses complex on decolorization) |
| Morphology | Common Organisms | Clinical Context |
|---|---|---|
| Gram+ cocci in clusters | Staphylococcus aureus, CoNS | Abscess, bacteremia, endocarditis |
| Gram+ cocci in chains | Streptococcus spp., Enterococcus | Pharyngitis, pneumonia, UTI |
| Gram+ diplococci (lancet-shaped) | S. pneumoniae | Pneumonia, meningitis |
| Gram- diplococci (coffee bean, intracellular) | Neisseria meningitidis, N. gonorrhoeae | Meningitis, urethritis, joint infection |
| Gram- rods (straight) | E. coli, Klebsiella, Pseudomonas, Proteus | UTI, pneumonia, wound infection |
| Gram+ rods (large, box-car shaped) | Clostridium, Bacillus | Wound infection, gas gangrene |
| Gram+ rods (small, tumbling motility) | Listeria monocytogenes | Meningitis in neonates, elderly, immunocompromised |
| Branching Gram+ filaments | Actinomyces, Nocardia | Abscess, pulmonary infection |
| No organisms visible | Consider: anaerobes, mycobacteria, fungi, viruses - use special stains |
| Stain | Used For | Result |
|---|---|---|
| Ziehl-Neelsen (AFB stain) | Mycobacteria, Nocardia | AFB = red/pink; background = blue |
| India ink | Cryptococcus neoformans in CSF | Clear halo (capsule) around organism |
| KOH preparation | Fungi | Clear fungal elements on dissolved background |
| Giemsa | Malaria, Chlamydia, Rickettsia | Varies |
| PAS | Fungi, Pneumocystis | Magenta cell walls |
| Error | Cause | Effect |
|---|---|---|
| Over-decolorized | Too long with acetone-alcohol | Gram+ appear pink (false Gram-) |
| Under-decolorized | Too little acetone-alcohol | Gram- appear purple (false Gram+) |
| Too thick smear | Overlapping cells | Poor resolution, missed organisms |
| Old culture | Aged bacteria lose Gram+ wall integrity | Gram-variable result |
| Type | Transmission Route | PPE Required | Room | Duration | Pathogens |
|---|---|---|---|---|---|
| Contact | Direct skin-to-skin or indirect via fomites | Gloves + gown (on room entry) | Single room or cohort | Until resolved | MRSA, VRE, C. difficile, scabies, impetigo, Shigella, norovirus, RSV |
| Droplet | Large droplets (>5 µm) - travel <1 metre | Surgical mask (on room entry), gloves | Single room; door may stay open | Until resolved (or for influenza: 5 days after symptom onset, 10 days if immunocompromised) | Influenza, meningococcal disease, pertussis, mumps, rubella, Haemophilus influenzae meningitis, SARS-CoV-2 (routine) |
| Airborne | Small droplet nuclei (<5 µm) - remain suspended in air, travel >1 metre | N95 respirator (fit-tested, seal-checked); gown + gloves | Negative-pressure room (≥12 air changes/hour), door kept CLOSED | TB: until 3 negative AFB smears on 3 consecutive days; measles/varicella: until lesions crusted | TB, measles, varicella/disseminated zoster, SARS-CoV-2 (aerosol-generating procedures) |
| Protective (Reverse) | Protect immunocompromised patient FROM environment | Mask on visitors + staff, gown + gloves | Positive-pressure room, HEPA filtration, avoid fresh flowers/plants | Duration of immunosuppression | Neutropenic patients (ANC <500), BMT recipients, severe combined immunodeficiency |
| Organism | 1/2 bottles positive | 2/2 sets positive |
|---|---|---|
| S. aureus | Likely true (always treat) | Definite bacteremia |
| E. coli, Klebsiella, Pseudomonas | Likely true | Definite bacteremia |
| CoNS (S. epidermidis) | Likely contaminant | Consider true if indwelling catheter |
| Bacillus, Corynebacterium, Propionibacterium | Almost always contaminant | Rarely true pathogen |
| Candida spp. | Always significant - fungemia | Mandates antifungal therapy |
| S. pneumoniae, Listeria | Always significant | Always treat |
| Organism | Media |
|---|---|
| GAS (S. pyogenes) | Blood agar (5% sheep blood) - beta haemolysis at 24-48h |
| Diphtheria | Loeffler's serum slope + Tellurite (CTBA) agar |
| N. gonorrhoeae | Modified Thayer-Martin (chocolate agar with antibiotics) - transport in CO₂ |
| Candida | Sabouraud dextrose agar |
| Suspected Organism | Test |
|---|---|
| Mycobacterium (TB, NTM) | AFB smear + culture on Lowenstein-Jensen media (4-8 weeks); PCR |
| Leishmania | Giemsa smear (look for amastigotes in macrophages); NNN media culture; PCR |
| Fungi (dermatophytes) | KOH prep; Sabouraud agar |
| HSV/VZV | Tzanck smear; PCR (most sensitive) |
| Actinomyces | Gram stain (Gram+ branching filaments); anaerobic culture |
| Nocardia | Modified AFB stain (weakly acid-fast); aerobic culture |
| Parameter | Normal | Bacterial Meningitis | Viral Meningitis | TB/Fungal Meningitis |
|---|---|---|---|---|
| Appearance | Clear, colourless | Turbid/cloudy, may be purulent | Clear | Clear to slightly turbid/xanthochromic |
| Opening pressure | <20 cm H₂O | Markedly elevated (>30 cm H₂O) | Normal or mildly elevated | Elevated |
| WBC (cells/µL) | 0-5 (lymphocytes) | >1000, often >10,000 | 10-1000 | 100-500 |
| Cell type | Lymphocytes | Neutrophils (>80%) | Lymphocytes | Lymphocytes |
| Protein (mg/dL) | 15-45 | Very high: >100-500 | Normal or slightly raised (45-100) | High: 100-500 |
| Glucose (mg/dL) | 50-80 (or >60% of serum) | Very low: <40 (often <20) | Normal (>60% serum) | Low: <45 |
| CSF:serum glucose ratio | >0.6 | <0.4 | >0.6 | <0.5 |
| Gram stain | Negative | Positive in 60-80% | Negative | Negative (AFB positive in <40%) |
| Organisms | None | Bacteria | None | India ink: Crypto; AFB: TB |
| Other tests | Bacterial antigen panel; PCR | Viral PCR (HSV, enterovirus) | Cryptococcal Ag; AFB culture; ADA level |
| Feature | Traumatic Tap | SAH |
|---|---|---|
| RBCs in CSF | Present | Present |
| RBC count across tubes 1→4 | Decreasing | Unchanged |
| Xanthochromia (after centrifugation) | Absent (if processed immediately) | Present (develops 2-4 hours after bleed) |
| Clotting in tubes | May occur | Rarely clots |
| WBC Pattern | Significance |
|---|---|
| Neutrophilia (>7,500/µL) with left shift | Bacterial infection, stress, steroid use, early sepsis |
| Band forms > 10% | Bacterial infection, early sepsis ("left shift") |
| Neutropenia (<1,500/µL) | Viral infections (typhoid, dengue, influenza), drugs, sepsis-induced bone marrow suppression |
| Lymphocytosis | Viral infections (EBV, CMV, acute HIV, pertussis), TB |
| Atypical lymphocytes > 10% | EBV, CMV, acute HIV, toxoplasmosis, hepatitis |
| Monocytosis | TB, brucellosis, typhoid, fungal infections, EBV |
| Eosinophilia | Parasitic infections (helminths esp.), fungal infections, drug reaction |
| Basophilia | Rare in infection; consider haematologic malignancy |
| Thrombocytopenia | Dengue (hallmark), malaria, sepsis-induced DIC, HUS, typhoid, HIV |
| Thrombocytosis (reactive) | Post-infectious, post-splenectomy |
| Biomarker | Reference Range | Interpretation |
|---|---|---|
| CRP | <5 mg/L | Rises within 6 hours, peaks at 48h. Rises with any inflammation (bacterial, viral, tissue damage). Not specific. Serial values more useful than single value. |
| ESR | <20 mm/hr (men), <30 mm/hr (women) | Slow to rise (24-48h), slow to normalise. Useful for chronic infections (TB, osteomyelitis, infective endocarditis) and monitoring treatment response. |
| Procalcitonin (PCT) | <0.1 ng/mL | PCT >0.5 ng/mL = suggestive of bacterial infection. PCT <0.1 ng/mL = bacterial infection less likely. PCT-guided protocols can safely reduce antibiotic duration in respiratory infections and sepsis. Caution: low PCT does NOT exclude severe bacterial infection - Washington Manual. Elevated in: bacterial sepsis, invasive fungal infection, severe burns/trauma. NOT elevated in: viral infections, localised infections (abscess without bacteremia), autoimmune disease. |
| Lactate | <2 mmol/L | >2 mmol/L = tissue hypoperfusion. Lactate ≥4 = septic shock. Serial lactate guides resuscitation (normalisation target per Surviving Sepsis Guidelines). |
| Ferritin | Variable | Markedly elevated (>10,000 µg/L) in: haemophagocytic lymphohistiocytosis (HLH), adult-onset Still's disease, severe sepsis, cytokine storm. |
| Pattern | Meaning |
|---|---|
| IgM positive, IgG negative | Acute/primary infection (within 1-2 weeks) |
| IgM positive, IgG positive | Recent infection (1-4 weeks, still in acute phase) |
| IgM negative, IgG positive | Past infection or vaccination (immunity) |
| Both negative | Not infected, no immunity |
| 4-fold rise in IgG titre (paired acute + convalescent, 2-4 weeks apart) | Confirms recent infection even if IgM is equivocal |
| Day of Illness | NS1 Ag | IgM | IgG | Interpretation |
|---|---|---|---|---|
| Days 1-5 | + | - | - | Early primary dengue |
| Days 5-9 | ± | + | - | Primary dengue |
| Days 5-9 | ± | + | + | Secondary dengue (worse prognosis, risk of severe dengue) |
| Day >10 | - | + | + | Late primary or secondary dengue |
| Drug | Adjustment Required in Renal Impairment |
|---|---|
| Aminoglycosides (gentamicin, amikacin) | Reduce dose OR extend interval; monitor trough levels; target trough <1 mg/L (gentamicin); nephrotoxic + ototoxic |
| Vancomycin | Reduce frequency (AUC/MIC guided dosing); target AUC 400-600 mg·h/L; monitor troughs or AUC |
| Acyclovir / Valacyclovir | Reduce dose; risk of crystalline nephropathy and encephalopathy |
| Fluconazole | Reduce dose by 50% if eGFR <50; IV formulation contains cyclodextrin - avoid if eGFR <50 |
| Piperacillin-tazobactam | Reduce dose/extend interval if eGFR <40 |
| Carbapenems | Dose reduction needed (all) |
| Colistin | Careful dose adjustment; highly nephrotoxic |
Give me a pdf of this
I didn't get the induration threshold in ppd